Long bones (femur, humerus, tibia, etc.) grow in length via endochondral ossification at the epiphyseal growth plate (physis). The growth plate has organised zones:

1. Reserve (resting) zone: Stores chondrocytes and nutrients.
2. Proliferative zone: Chondrocytes divide rapidly, forming columns ("stacks of coins"). This is the zone that drives longitudinal bone growth.
3. Hypertrophic zone: Chondrocytes enlarge (hypertrophy), begin to calcify their matrix, and eventually undergo apoptosis.
4. Calcification/Ossification zone: Osteoblasts invade and lay down true bone on the calcified cartilage scaffold.

FGFR3's normal role: FGFR3 is expressed predominantly in the proliferative zone of the growth plate. When FGF ligands bind FGFR3, it sends inhibitory ("stop growing") signals to chondrocytes:

• Activates STAT1 pathway → inhibits chondrocyte proliferation
• Activates MAPK/ERK pathway → promotes premature differentiation and apoptosis of chondrocytes
• Inhibits IHH (Indian Hedgehog) and BMP signalling pathways that normally promote growth

Think of FGFR3 as the "brake pedal" on bone growth. Normally, the brake is applied intermittently. In achondroplasia, the brake is stuck on (constitutively active).

This distinction explains the disproportionate phenotype: limbs are short (endochondral), but the skull vault is normal or large (membranous).

• Mutation in the FGFR3 gene located on chromosome 4p16.3 ^[1][2].
• The mutation is remarkably specific and recurrent:
  • > 97% of cases: G380R — a glycine to arginine substitution at codon 380 in the transmembrane domain of FGFR3.
  • Specifically, a G→A transition at nucleotide 1138 (most common) or a G→C transversion at nucleotide 1138.
• This is a gain-of-function mutation: the mutant receptor is constitutively active even without ligand binding.

Achondroplasia falls under disproportionate short stature — this is a critical distinction:

In achondroplasia, the shortening is "rhizomelic" — meaning the proximal segments (humerus, femur) are more affected than the distal segments (forearm, lower leg). "Rhizo-" = root, referring to the root/proximal part of the limb ^[1][2].

• Gene: Type I collagen (COL1A1/COL1A2 mutations in most types)
• Inheritance: Mostly AD (types I and IV); type II can be AD de novo (lethal)
• Pathophysiology: A group of rare inherited disorders of type 1 collagen → bone fragility → bowing and frequent fractures ^[1]
• Why it enters the differential: OI can cause short stature with limb bowing, which superficially resembles the bowed legs and short stature of achondroplasia. However:
  • In OI, the short stature is due to fractures and bone deformity, NOT impaired endochondral ossification
  • Blue sclerae (thin sclera allows choroidal veins to show through — collagen is a major structural component of sclera)
  • Hearing loss (otosclerosis — abnormal collagen in ossicles)
  • Dentinogenesis imperfecta (opalescent, fragile teeth — collagen is in dentine)
  • No macrocephaly, frontal bossing, or trident hand
• Type I (most common): AD, fractures + blue sclera ± hearing loss ^[1]
• Type II: AD, lethal form with multiple fractures before birth ^[1]

• Inheritance: Usually AR (severe infantile form), can also be AD (less severe adult form) ^[1]
• Pathophysiology: Defective osteoclast function → failure of bone resorption → dense, brittle bones that paradoxically fracture easily (bones are hard but not tough — think of marble: dense but shatters under impact)
• S/S: Dense brittle bone, FTT, recurrent infection, hypocalcaemia, anaemia, thrombocytopenia ^[1]
  • Why cytopenias? The excessively dense bone encroaches on the medullary cavity, leaving no room for haematopoietic marrow → bone marrow failure → anaemia, thrombocytopenia, leucopenia → extramedullary haematopoiesis (hepatosplenomegaly)
  • Why hypocalcaemia? Osteoclasts normally release calcium during bone resorption; without resorption, calcium stays locked in bone
  • Why recurrent infections? Neutropenia from marrow failure + dysfunctional immune response
• Prognosis: Poor, but can be cured by BMT ^[1] (transplanted donor stem cells give rise to functional osteoclasts)
• Why it enters the differential: Both osteopetrosis and achondroplasia cause short stature. However, osteopetrosis has dense bones (opposite of osteopenia), cranial nerve palsies (foramina narrowed by dense bone), and pancytopenia — features absent in achondroplasia.

• Clinical features: Disproportionately short stature + kyphoscoliosis ^[5]
• Key difference from achondroplasia: In SED, the trunk is disproportionately short (short trunk dwarfism), whereas in achondroplasia the limbs are disproportionately short (short limb dwarfism)
• Pathophysiology: Defect in type II collagen (COL2A1 mutations) → affects vertebral bodies and epiphyses
• Investigation: Skeletal survey ^[5]
• Management: Manage complications ^[5]

• Gene: RUNX2 (also called CBFA1) — a master regulator of osteoblast differentiation
• Inheritance: AD
• Clinical presentation ^[1]:
  • Short stature
  • Absence of part or entire clavicles: often can bring shoulders together in front of chest — the pathognomonic sign (ask the child to approximate their shoulders anteriorly)
  • Delayed closure of anterior fontanelle
  • Supernumerary teeth, delayed eruption of permanent teeth
• Why it enters the differential: Short stature + skeletal abnormality. However, the clavicular aplasia/hypoplasia and persistent open fontanelle are not features of achondroplasia, making distinction straightforward.

• "Arthro-" (joint) + "gryposis" (curved/hooked) — literally "curved joints"
• Etiology: Usually sporadic, occasionally associated with underlying neurological/muscle disease ^[1]
• Clinical presentation ^[1]:
  • Joint stiffness and contracture ± dislocation
  • Other joint deformities, e.g. talipes equinovarus, scoliosis
  • Decreased skin/subcutaneous tissue and marked muscle atrophy around affected joints
• Why it enters the differential: Can cause apparent short stature and limb deformities in a neonate/infant. However, the hallmark is joint contractures with muscle wasting, not disproportionate shortening. Limb lengths may be normal but the limbs appear abnormal due to contractures.

The diagnosis of achondroplasia can be made clinically when the following constellation of features is present:

• Gold standard: Detection of the FGFR3 c.1138G>A (or c.1138G>C) mutation resulting in the p.Gly380Arg (G380R) amino acid substitution
• This single mutation accounts for > 97% of achondroplasia cases
• Testing is performed via targeted mutation analysis (Sanger sequencing or allele-specific PCR) on a blood sample (DNA extracted from peripheral blood leucocytes)
• If the G380R mutation is not found but clinical suspicion remains, broader FGFR3 gene sequencing or a skeletal dysplasia gene panel should be performed to identify rarer mutations or alternative diagnoses (e.g., hypochondroplasia, thanatophoric dysplasia)

A skeletal survey (a series of plain radiographs covering the entire skeleton) is the key radiological investigation. The characteristic findings in achondroplasia are so distinctive that an experienced radiologist can make the diagnosis from the films alone.

This is the first-line "investigation" — it is non-invasive and done at every clinical encounter.

Always plot measurements on achondroplasia-specific growth charts ^[1][4]. These charts were developed by Horton et al. (1978, updated by del Pino et al. 2018) and are freely available. Plotting on standard WHO charts will show all parameters as "abnormal" and is not clinically useful.

Interpretation notes:

• A positive FGFR3 G380R result is diagnostic — no further genetic testing is needed for the skeletal diagnosis
• A negative result does NOT exclude skeletal dysplasia — it means the specific achondroplasia mutation is absent, and alternative diagnoses should be considered
• Cell-free fetal DNA (cfDNA): Non-invasive prenatal testing (NIPT) can detect FGFR3 mutations in maternal blood from ~10 weeks gestation. This avoids the procedural risks of CVS/amniocentesis. Sensitivity is high (> 99%) but is primarily used when one parent is affected and the specific familial mutation is known.

This is arguably the most clinically important investigation in the first year of life for achondroplasia.

When to obtain MRI craniocervical junction?

• All infants with confirmed achondroplasia should have a baseline MRI of the craniocervical junction, ideally by 6–12 months of age (American Academy of Pediatrics guideline)
• Urgently if any red flags: central apnoea on polysomnography, severe hypotonia, hyperreflexia, clonus, feeding difficulties, or developmental regression
• Brain MRI simultaneously to assess ventricular size

• Recommendation: All infants with achondroplasia should have a baseline polysomnography by 6–12 months of age, and it should be repeated if clinically indicated
• Why it matters: Central apnoea may be clinically silent until a life-threatening event occurs; polysomnography detects it before catastrophe
• Interpretation threshold: An apnoea-hypopnoea index (AHI) > 1 event/hour in a child is considered abnormal; central apnoea index > 1 event/hour is particularly concerning in achondroplasia

• Recommendation: Audiology assessment by 12 months, then annually in early childhood
• Untreated hearing loss impairs speech and language development — early intervention (grommets, hearing aids) is critical

Achondroplasia is primarily a clinical and radiological/genetic diagnosis. Blood tests are not diagnostic but are important for baseline assessment and monitoring:

For the prenatal diagnosis scenario (commonly asked in exams):

• GH replacement has been used historically in achondroplasia ^[1]
• Rationale: GH stimulates IGF-1, which promotes chondrocyte proliferation at the growth plate. The idea was that extra GH might partially overcome the FGFR3-mediated growth inhibition.
• Evidence: GH therapy produces a modest increase in growth velocity in the first 1–2 years (typically 1–3 cm/year above baseline), but the effect wanes over time and the final adult height gain is limited (~3–5 cm at best)
• Why it has limited benefit: The fundamental problem in achondroplasia is not GH deficiency — GH and IGF-1 levels are normal. The problem is downstream at the growth plate (FGFR3 overactivation directly inhibits chondrocyte response). Adding more "gas" (GH) doesn't help much when the "brake" (FGFR3) is stuck on.
• Current status: GH is not first-line for achondroplasia now that vosoritide is available. Some centres still use it where vosoritide is not accessible, or in combination. It is used off-label (not specifically licensed for achondroplasia in most jurisdictions).

• Indication: Symptomatic cervicomedullary compression — central apnoea, myelopathic signs (hyperreflexia, clonus), severe hypotonia, significant cord compression on MRI
• Procedure: Suboccipital craniectomy ± upper cervical laminectomy (C1 ± C2) to enlarge the foramen magnum and decompress the cervicomedullary junction. Some cases also require duraplasty (opening and patching the dura to create more space).
• Timing: Urgent/emergent if symptomatic. Even in asymptomatic cases with significant imaging abnormalities (e.g., cord signal change, absent CSF space), prophylactic decompression may be discussed.
• Contraindications: Standard surgical contraindications; unstable patient; must assess for atlanto-axial instability pre-operatively (can coexist)
• Paediatric anaesthetic considerations: Achondroplasia children are high-risk for anaesthesia due to:
  • Difficult airway (midface hypoplasia, short neck, potential subglottic stenosis)
  • Foramen magnum stenosis itself (neck extension during intubation can worsen compression)
  • Small thorax and potential restrictive lung disease
  • Fibreoptic intubation or careful video laryngoscopy is preferred; avoid excessive neck extension

• Limb lengthening surgery is offered as a management option in achondroplasia ^[1]
• Principle: Based on distraction osteogenesis (Ilizarov principle) — a controlled osteotomy (surgical bone cut) is performed, then the bone segments are slowly distracted apart (~1 mm/day) using an external fixator. New bone forms in the gap (regenerate).
• Bones targeted: Usually bilateral femora and bilateral tibiae/fibulae (lower limbs) ± humeri (upper limbs). Often staged over multiple operations over several years.
• Potential height gain: 10–15+ cm in total over multiple limb segments
• Indications:
  • Patient desire for increased stature and functional improvement (e.g., reaching objects, driving, social participation)
  • Typically offered in late childhood or adolescence (age 8–14 years, with skeletal maturity considerations)
  • Requires extensive patient and family counselling about the prolonged, demanding process
• Contraindications/Cautions:
  • Very young children (insufficient bone stock, compliance issues)
  • Patient/family not fully informed or committed (the process takes months per segment with external fixators, requiring diligent pin-site care and physiotherapy)
  • Active infection, severe osteoporosis (rare in achondroplasia)
• Complications:
  • Pin-site infection (most common)
  • Premature consolidation (bone heals before adequate length gained)
  • Delayed union or non-union
  • Joint contracture/stiffness (especially knee)
  • Neurovascular injury (nerve stretching during distraction)
  • Psychological burden (long treatment, restricted activity)
• Ethical consideration (Paediatric-specific): This is an elective procedure. The decision must involve the child's assent (age-appropriate understanding and agreement), not just parental consent. The child must understand the commitment, risks, pain, and expected outcomes. Many achondroplasia advocacy groups have strong opinions both for and against limb lengthening — the clinician's role is to provide balanced information and support the family's decision.

• Indication: Symptomatic lumbar spinal stenosis — neurogenic claudication (leg pain/weakness with walking, relieved by rest/flexion), myelopathy, cauda equina syndrome, bladder/bowel dysfunction
• Procedure: Decompressive laminectomy ± fusion (multilevel, because stenosis is typically diffuse in achondroplasia due to short pedicles throughout)
• Timing: Typically in adolescence or young adulthood when symptoms develop, though can occur in older children
• Paediatric consideration: In children, conservative management (activity modification, physiotherapy, weight management to reduce mechanical load) is tried first; surgery is reserved for progressive neurological deficit or intractable symptoms

• Indication: Progressive, symptomatic genu varum (bowlegs) causing functional impairment, pain, or risk of joint degeneration
• Procedures:
  • Guided growth (hemiepiphysiodesis): Temporary restraint of the lateral growth plate of the proximal tibia/distal femur using a tension-band plate (e.g., eight-plate). This allows the medial side to "catch up" and gradually correct the varus. Only works while growth plates are open — a paediatric-specific technique.
  • Corrective osteotomy: If growth plates are closed or deformity is severe, a formal osteotomy (bone cut and realignment) with internal fixation is performed.
• Timing: Guided growth is best done early (age 4–8 years) when there is substantial growth remaining. Osteotomy can be done at any age.

• Indication: Progressive symptomatic hydrocephalus (increasing head circumference crossing achondroplasia-specific centiles, bulging fontanelle, irritability, vomiting, sunsetting sign, developmental regression)
• Note: Most children with achondroplasia have ventriculomegaly that is stable and asymptomatic — this does NOT require shunting. Only progressive, symptomatic hydrocephalus warrants surgical intervention.
• Procedure: Standard VP shunt placement by neurosurgery.

• Indication: Moderate-severe OSA on polysomnography with adenotonsillar hypertrophy
• Procedure: Standard ENT adenotonsillectomy
• Note: If OSA persists post-adenotonsillectomy (common in achondroplasia due to midface hypoplasia and small airway), CPAP or midface advancement surgery may be needed.

The foramen magnum is formed by the basiocciput and exoccipital bones, which grow by endochondral ossification. In achondroplasia, impaired endochondral growth results in a small, narrow foramen magnum. The normal-sized brainstem and upper cervical spinal cord must pass through this constricted opening → compression of the cervicomedullary junction (the transition zone between the medulla oblongata and upper spinal cord).

The medulla contains the vital centres for:

• Respiratory drive (dorsal and ventral respiratory groups) → compression causes central apnoea
• Cardiovascular regulation (vasomotor centre) → autonomic instability
• Descending motor tracts (corticospinal tracts decussate here) → upper motor neuron signs, quadriparesis

• Sudden unexpected death occurs in approximately 2–5% of infants with achondroplasia, predominantly attributed to cervicomedullary compression and/or central apnoea
• With modern surveillance (baseline MRI at 6–12 months, polysomnography) and timely foramen magnum decompression, mortality has been significantly reduced
• Post-decompression, most infants show neurological improvement; the earlier the intervention, the better the outcome

Children with achondroplasia almost universally have ventriculomegaly (enlarged ventricles). This occurs through two mechanisms:

1. Impaired venous outflow: The jugular foramina (through which the internal jugular veins drain intracranial blood) are formed by endochondral ossification → narrowed in achondroplasia → increased intracranial venous pressure → reduced CSF absorption at the arachnoid granulations (CSF is absorbed into venous sinuses — if venous pressure is high, the pressure gradient for absorption is reduced)
2. Small posterior fossa: The posterior fossa (formed by endochondral bone) is small → less space for cerebellum and brainstem → relative crowding → may contribute to obstructive component at the level of the 4th ventricle outflow

This is typically communicating hydrocephalus (all ventricles enlarged, no discrete obstruction point), though a mixed component can occur.

Most ventriculomegaly in achondroplasia is stable and does not require intervention. Only progressive, symptomatic hydrocephalus warrants VP shunt placement. Over-shunting must also be avoided. Serial imaging (cranial ultrasound while fontanelle open → MRI thereafter) with correlation to clinical status is essential.

This is one of the most functionally debilitating long-term complications and is virtually universal to some degree.

• Vertebral pedicles grow by endochondral ossification → short in achondroplasia → narrowed anteroposterior diameter of the spinal canal at every level
• The interpedicular distance decreases from L1 to L5 (pathognomonic radiological sign — normally it increases caudally)
• Combined with disc bulging, facet joint hypertrophy, and ligamentum flavum thickening (which occur with age), the already-narrow canal becomes critically stenotic

Excess weight in a person with achondroplasia has a disproportionate effect on the spine:

• The spine is already structurally compromised (short pedicles, narrow canal, exaggerated lordosis)
• Increased axial load from obesity accelerates degenerative changes (disc disease, facet hypertrophy, ligamentum flavum thickening)
• These secondary changes further narrow the already-small canal → earlier and more severe symptomatic stenosis
• Maintaining weight on the 25th percentile for achondroplasia is therefore a critical preventive strategy ^[2]

• Thoracolumbar kyphosis (gibbus) is present in infancy ^[1] — caused by:
  • Vertebral body wedging (anterior height less than posterior due to impaired endochondral growth)
  • Infantile hypotonia (poor trunk muscle support)
  • Gravity acting on the unsupported thoracolumbar junction when the infant sits
• With ambulation (typically 18–24 months), most children develop compensatory lumbar hyperlordosis — the exaggerated lordosis shifts the centre of gravity posteriorly to compensate for the relative upper body heaviness (large head, short trunk)
• In some children, the thoracolumbar kyphosis persists or progresses — if the angular kyphosis exceeds ~30–40°, it may require bracing or, rarely, surgical correction (spinal fusion) to prevent neurological compromise

The GC lecture slides explicitly state preventive measures ^[2]:

• Firm back support from birth — supports the developing spine
• Reclined seating (delayed upright sitting) and reclined handling — reduces axial load on the thoracolumbar junction before trunk muscles are strong enough to support the heavy head
• Prone play in older infants — strengthens paraspinal extensor muscles
• Trunk strengthening exercises — builds core musculature to stabilise the spine

The reasoning is straightforward: if you reduce the mechanical forces that cause the kyphosis to worsen (axial loading before muscle readiness) and strengthen the muscles that resist kyphosis (back extensors), you reduce the severity of the deformity and its downstream complications.

Sleep apnoea in achondroplasia has two distinct components, often coexisting:

• Sleep-disordered breathing affects 50–75% of children with achondroplasia to some degree
• OSA is the more common component in older children
• CSA is the more dangerous component and is more common in infancy

• Eustachian tube dysfunction: The Eustachian tube runs from the middle ear to the nasopharynx. In achondroplasia, midface hypoplasia → short, dysfunctional Eustachian tubes that fail to equalise middle ear pressure and drain secretions adequately
• Chronic middle ear effusion → recurrent acute otitis media → conductive hearing loss
• Some children may also develop sensorineural hearing loss (mechanism less clear — possibly related to cochlear blood supply or cervicomedullary compression affecting auditory pathways)

• Hearing loss in the first 3 years of life is critical because this is the period of maximal speech and language acquisition
• Even mild conductive hearing loss (15–25 dB) can significantly impair speech development, social communication, and later academic performance
• Early detection (audiometry by 12 months) and intervention (grommets/ventilation tubes, hearing aids) is essential

• Asymmetric growth plate activity: Lateral tibial growth plate and fibular growth may proceed at a relatively different rate compared to the medial tibial growth plate
• Fibular overgrowth relative to tibia: The fibula is less affected by FGFR3 overactivation → grows relatively longer → pushes the ankle laterally → contributes to varus alignment
• Ligamentous laxity: Common in achondroplasia → allows lateral thrust of the knee during weight-bearing
• These factors combine to produce progressive genu varum once the child starts weight-bearing

This is a preventable complication but one of the most common and impactful.

• Children with achondroplasia have a small body frame with lower basal metabolic rate → lower caloric needs than average-sized peers
• However, they are often fed portions similar to peers → caloric excess
• Reduced physical activity: Short limbs, joint limitations, spinal stenosis, and avoidance of certain sports (cervical spine risk) reduce energy expenditure
• Psychological factors: Comfort eating, social isolation

Obesity → ↑ Axial spinal load → Accelerated spinal stenosis → Earlier neurogenic claudication
       → ↑ Airway soft tissue → Worsened OSA → Chronic hypoxia → Pulmonary hypertension
       → ↑ Metabolic risk → Insulin resistance, dyslipidaemia, hypertension → Cardiovascular disease
       → ↓ Mobility → Further weight gain (vicious cycle)

Maintaining weight on the 25th percentile for achondroplasia is explicitly recommended in the GC 151 lecture ^[2]. This is perhaps the single most impactful modifiable factor in the long-term outcome of achondroplasia.